Viewing StudyNCT04633239



Ignite Creation Date: 2024-05-06 @ 3:27 PM
Last Modification Date: 2024-10-26 @ 1:49 PM
Study NCT ID: NCT04633239
Status: RECRUITING
Last Update Posted: 2024-07-15
First Post: 2020-11-17

Brief Title: Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Recurrent Platinum-Resistant Ovarian Carcinoma
Recurrent Ovarian High Grade Serous Adenocarcinoma
Keywords: